FSD Pharma Commences Proceedings Against Dissident Shareholders
Mar 31, 2021
FSD Pharma Enters into License Agreement to Develop FDA approved Veterinary Drugs for the Treatment of Gastro-Intestinal Diseases in Dogs and Cats
Mar 16, 2021
FSD Pharma Announces US$20M At-The-Market Offering
Feb 11, 2021
FSD Provides Corporate Update
Jan 26, 2021
FSD Pharma Sets Date for Annual Meeting
Jan 22, 2021
FSD Pharma Announces First Patient Randomized in Phase 2 Trial of FSD201 for the Treatment of Hospitalized Patients with COVID-19
Dec 15, 2020
FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update
Nov 12, 2020
FSD Pharma Announces Settlement of Class Action Proceeding
Oct 29, 2020